InsiderClue
← All stocks

LB PHARMACEUTICALS INC

LBRX Net buying
CIK 0001691082 #2237 in the set updated 18 Sep 2026
Bought (120 mo)
$75.00M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$75.00M
+$75.00M against sales at will

By person

4 insiders · 6 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Deep Track Biotechnology Master Fund, Ltd. entity
10% owner
$40.00M (2)
—
+$40.00M
3,352,804
10.39%
$50.29M
—
Nussbaum Ran
Director
$15.00M (1)
—
+$15.00M
1,411,681
4.38%
$21.18M
—
Pontifax Management 4 G.P. (2015) Ltd. entity
10% owner
$15.00M (1)
—
+$15.00M
1,411,681
4.38%
$21.18M
—
Vida Ventures GP III, L.L.C. entity
10% owner
$5.00M (2)
—
+$5.00M
2,029
0.0063%
$30.44K
—

Individual transactions

6
Insider
Date
Role
Action
Shares
Price
Amount
Vida Ventures GP III, L.L.C.
12 Sep 2025
10% owner
Buy indirect
767
$15.00
$11.51K
Vida Ventures GP III, L.L.C.
12 Sep 2025
10% owner
Buy indirect
332,566
$15.00
$4.99M
Nussbaum Ran
12 Sep 2025
Director
Buy indirect
1,000,000
$15.00
$15.00M
Pontifax Management 4 G.P. (2015) Ltd.
12 Sep 2025
10% owner
Buy indirect
1,000,000
$15.00
$15.00M
Deep Track Biotechnology Master Fund, Ltd.
12 Sep 2025
10% owner
Buy indirect
666,666
$15.00
$10.00M
Deep Track Biotechnology Master Fund, Ltd.
12 Sep 2025
10% owner
Buy
2,000,000
$15.00
$30.00M
Show all 6 transactions →

What was left out

Form 4 filings counted 27
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 2,058,410
History held since 12 Sep 2025